1988
DOI: 10.1016/0893-133x(88)90020-6
|View full text |Cite
|
Sign up to set email alerts
|

Supersensitivity to melatonin suppression by light in young people at high risk for affective disorder A preliminary report

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
47
0

Year Published

1998
1998
2015
2015

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 103 publications
(50 citation statements)
references
References 0 publications
2
47
0
Order By: Relevance
“…In contrast patients with MDD did not demonstrate significantly different suppression of nocturnal plasma melatonin concentrations following light exposure when compared to controls. The findings are similar to that of Lewy et al (1981Lewy et al ( , 1985 and Nurnberger et al (1988) who likewise found a supersensitivity in bipolar patients, and Cummings et al (1989) who found no difference in the light sensitivity between controls and patients with MDD. However, the study does not agree with a more recent study that showed more suppression in the controls than in a group of patients with MDD or BD (Lam et al 1990), and the study of Whalley et al (1990) showing no differences in sensitivity to 500 lux between euthymic (recovered) bipolar patients and control subjects.…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…In contrast patients with MDD did not demonstrate significantly different suppression of nocturnal plasma melatonin concentrations following light exposure when compared to controls. The findings are similar to that of Lewy et al (1981Lewy et al ( , 1985 and Nurnberger et al (1988) who likewise found a supersensitivity in bipolar patients, and Cummings et al (1989) who found no difference in the light sensitivity between controls and patients with MDD. However, the study does not agree with a more recent study that showed more suppression in the controls than in a group of patients with MDD or BD (Lam et al 1990), and the study of Whalley et al (1990) showing no differences in sensitivity to 500 lux between euthymic (recovered) bipolar patients and control subjects.…”
Section: Discussionsupporting
confidence: 90%
“…Early reports suggested bipolar disorder patients were supersensitive to the effects 500 lux of light (Lewy et al 1981) and that this may be a trait marker for the illness (Lewy et al 1985). Nurnberger et al (1988) have taken this hypothesis further and investigated familial sensitivity as a possible genetic marker. It was reported that the supersensitivity in the melatonin response to light was more likely amongst those with a parent with bipolar disorder.…”
mentioning
confidence: 99%
“…If replicated in larger sample sizes, the data would suggest that PMDD patients may be more sensitive than NC subjects to the acute suppressive effects of light on melatonin secretion as were the depressed vs. control subjects reported in initial studies by Lewy et al (1981) and Nurnberger et al (1988).…”
Section: Premenstrual Dysphoric Disordermentioning
confidence: 91%
“…At ¢rst sight, there is a con£ict between our suggestion that the primary defect is a reduction in cationic channels and the many ¢ndings of increased cellular and neuronal sensitivity in bipolar disorder, as cationic-channel reduction would have the general e¡ect of decreased neuronal sensitivity. Documented examples of increased neuronal sensitivity in bipolar disorder include: (i) elevated levels of G proteins (Mitchell et al 1997); (ii) increased responsiveness of cAMP processes (Andreopoulos et al 1997); (iii) increased sensitivity to light-induced melatonin suppression (Nurnberger et al 1988); and (iv) increased sensitivity to cholinergic REM sleep induction (Nurnberger et al 1983). We suggest that these apparent contradictions can be resolved if the primary e¡ect on the timing of the oscillator is distinguished from the`downstream' e¡ects on other parts of the brain, such as the cerebral hemispheres, where compensatory mechanisms may be used to restore normal levels of excitability in the face of reduced cationicchannel function.…”
Section: Discussion (A) Geneticsmentioning
confidence: 99%